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Fifty-six young central obese patients were investigated to evaluate relationships between soluble E-selectin (sE-S), angio-
tensin-converting enzyme (ACE) gene polymorphism, left ventricular function and structure, and carotid morphology by
determination of sE-S and ACE genotypes. Our results indicated that central obese subjects with concomitant higher levels
of sE-S and ACE DD genotype may be characterized by early cardiovascular alterations and then considered a particular
subset of subjects at higher risk of cardiovascular disease.
© 2003 Elsevier Inc. All rights reserved.
CENTRAL OBESITY has to be considered today anemerging risk factor for atherosclerotic cardiovascular
disease.1-3 In fact, an atherogenic metabolic profile,4 a pro-
thrombotic hypofibrinolitic pattern,5 an altered sodium-regulat-
ing hormone control,6 and a silent left ventricular dysfunc-
tion7,8 may be detectable early in young central obese subjects.
On the other hand, it is known that structural or functional
changes in vascular endothelium are involved in the pathogen-
esis of atherosclerotic vascular diseases. In fact, it has to be
emphasized that endothelium may react to several stimuli with
dysfunctional responses.9
An impaired endothelium-dependent vasodilation has been
reported not only in clinically overt atherosclerosis,10 but also
in some subsets of patients at higher cardiovascular risk such as
hypertensives, hyperdyslipidemics, and diabetics.10-12 This ab-
normality is consistent with a rapid adhesion and aggregation
of platelet at the sites of the injury, and in the activation of the
coagulation cascade.9,13 It has recently been reported that en-
dothelial function may be evaluated looking for some endothe-
lial molecules that are expressed and amplified when an endo-
thelial injury occurs. Accordingly, an important role has been
attributed to endothelium-bound E-selectin. In fact, this endo-
thelium-specific molecule is able to mediate the initial phase
(rolling) of adhesion of leukocytes to endothelium.9,14 In addi-
tion, soluble E-selectin (sE-S) has been recently proposed as a
new and early marker of endothelial injury/damage.15-17
Moreover, despite the role of angiotensin-converting enzyme
(ACE), DD genotype as a cardiac risk factor remains contro-
versial.18-20 The D allele has been consistently associated with
higher ACE activity or angiotensin II levels across distinct
patient populations, including hypertensive and central obese
subjects.20,21 The changes in ACE activity associated with the
D allele could affect endothelial function by 2 potential mech-
anisms. First, an increase in plasma ACE may promote angio-
tensin I to angiotensin II conversion and therefore amplification
of the generation of superoxide anions that degrade nitric oxide
(NO). Second, high ACE levels may increase bradikynin deg-
radation and therefore reduce bradykynin-induced NO ef-
fects.22 Although these data suggest a pathophysiological con-
nection between the D allele and endothelial dysfunction, at
present, few data are available on the relation between central
obesity, endothelial function, ACE genotypes, and atheroscle-
rosis. The current study was designed to analyze the pattern of
sE-S and ACE genotypes in young central obese subjects
without major risk factors for cardiovascular disease and their
relationships with early markers of cardiovascular damage. The
main goal of the study was to evaluate whether higher circu-
lating E-selectin values and homozygosity for the D allele of
ACE could contribute to the early recognition subset of central
obese subjects with a higher susceptibility to atherosclerotic
cardiovascular disease.
MATERIALS AND METHODS
Subjects
A total of 56 obese subjects younger than 40 years of age with
central fat distribution were included in the study. Obese subjects were
consecutively recruited in the obesity center of the Internal Medicine
Department at the University of Palermo (Italy). The subjects were
classified as obese according to sex-specific 85th percentile of body
mass index (BMI) values, as reported at the Italian Consensus Confer-
ence on Obesity.23 Accordingly, males with a BMI greater than 30.5
kg/m2 and females with a BMI greater than 27.3 kg/m2 were considered
obese. Body fat distribution was evaluated by measuring waist-to-hip
ratio (WHR) in the standing position, as previously reported.24,25 Cen-
tral obesity was defined according to the sex-specific 85th percentile of
WHR values. Males with WHR values 0.92 and females with WHR
values 0.81 were considered to have central obesity.4,23-25
Accordingly, accurate family and clinical history and laboratory
investigations were obtained. Exclusion criteria were smoking habits,
hypertension (according to International Society of Hypertension [ISH]
guidelines, arterial pressure was recorded with an appropriate large cuff
in obese subjects), cardiovascular diseases (defined as myocardial
infarction, chest pain, heart block, valvular disease, and heart failure),
renal disease, insulin-dependent or -independent diabetes mellitus, fa-
milial hyperdyslipidemia, electrolyte imbalances, alcoholism, or psy-
chiatric problems. The study was approved by the Ethics Committee of
University of Palermo School of Medicine and each patient gave
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informed consent after receiving a detailed description of the study
procedure. Preliminary investigations included measurements of blood
and urinary electrolytes, creatinine clearance, and blood sugar both
basal and after an oral glucose tolerance test. In addition, basal immu-
noreactive insulin levels (IRIb) and 2-hour post–glucose tolerance test
(2h-IRI) values were recorded.
Methods
Measurements ofsE-S. sE-S was measured in all sera by sandwich
enzyme immunoassay purchased from Bender Medsystem (Vienna,
Austria) following the manufacturer’s instructions. Sensitivity, and
interassay and intra-assay variability were validated in our laboratory
and were comparable to those obtained by the manufacturer.26 Results
were expressed as nanograms per milliliter.
Levels of sE-S were determined in all subjects and grouped accord-
ing to level: less than 80 ng/mL (group A) and 80 ng/mL (group B).
Group A patients with a normal sE-S value consisted of 42 central
obese subjects (29 men and 22 women), with a mean sE-S value of
54  13 and a mean age of 33  5 years. Group B patients with higher
sE-S values consisted of 14 central obese subjects (6 men and 8
women) with a mean sE-S value of 99  15 and a mean age of 35 
3 years.
The cut-off value of sE-S was related to the mean value 2 SD of
young healthy control sample (without a family history of premature
cardiovascular disease) from our laboratory.26 Our mean values re-
ported in normal subjects are in agreement with those reported by
others.27,28
Determination of ACE genotypes. The D and I alleles were iden-
tified on the basis of polymerase chain reaction (PCR) amplification of
the respective fragments from intron 16 of the ACE gene and size
fractionation and visualization by electrophoresis gel. For preparing
PCR templates from human whole blood, we used the Split Second
DNA Preparation Kit (Boehringer Mannheim, Germany).
We used an optimized primer pair to amplify the D and I alleles,
resulting in 319-bp and 597-bp amplicons, respectively, hace3s and
hace3as. The amplification products of the D and I alleles were iden-
tified by 300-nm ultraviolet transillumination as distinct bands; in
heterozygous samples, a third band, assumed to represent a heterodu-
plex DNA product, was commonly seen.
Because the D allele in heterozygous is amplified preferentially, each
sample found to have the DD genotype was subjected to a second
independent PCR amplification with a primer pair that recognizes an
insertion-specific sequence, hace5a and hace5c, with identical PCR
conditions except for an annealing temperature of 67°C. The reaction
yields a 335-bp amplicon only in the presence of an I allele, and no
product in samples homozygous for DD. This procedure correctly
identified the 4% to 5% of samples with the DI genotype that are
misclassified as DD with the insertion-spanning primers.
Casual and 24-hour blood pressure. Casual systolic and diastolic
blood pressure (SBPc and DBPc) were measured in triplicate by
mercury sphygmomanometer with subjects in the supine position.
DBPc refers to Korotkoff V phase. Casual mean blood pressure
(MBPc) was calculated from the sum of DBPc plus one third of the
arterial pulse pressure. Arterial pressure was measured with an appro-
priately wide cuff in all subjects. Heart rate was evaluated by electro-
cardiographic tracing.4,29,30
Ambulatory blood pressure was recorded by the portable fully au-
tomatic Takeda (Japan) TM2420 system connected through the serial
interface (RS 232) to an IBM (Italy) personal system 2 computer,
which in our laboratory showed a correlation of r 0.96 for both SBPc
and DBPc.23,24,29 An appropriately large cuff was available to allow
precise 24-hour blood pressure readings in obese subjects. This ap-
proach was well tolerated by all patients. The 24-hour mean SBP, DBP,
and MBP were calculated.
Echocardiographic measurements. Left ventricular mass (LVM),
LVM indexed for the body height (LVM/h), and cardiac output
(CO) were calculated by echocardiographic findings, as previously
reported.25,31
Two-dimensional and M-mode echocardiography examination was
performed by an Esaote Biomedica (Italy) computer-aided ultrasound
system equipped with 2.5- and 3.5-MHz faced array transducers and a
standard VHS video system.
Left ventricular ejection fraction (LVEF) by left ventricular end
diastolic and end systolic volumes was measured from the apical
4-chamber view, using the ellipsoid single-plane algorithm. Mean EF
was automatically calculated by the echocardiography processing sys-
tem. In our laboratory the EF calculated on 5 consecutive beats per-
mitted optimal reproducibility and accuracy.31
Total peripheral resistance (TPR) was calculated by the formula:
MBP  80  1,332/CO and expressed as dynes  s  cm5.
Carotid measurements. In all the subjects, an ultrasound high-
resolution B-mode imaging examination of the common carotid arteries
with scanning on the longitudinal axis until the bifurcation and on the
transversal axis was performed using an instrument generating a wide-
band ultrasonic pulse with a middle frequency of 7.5 MHz (Toshiba
SSA-270°, Tokyo, Japan).
Intima media wall thickness (IMWT) and lumen diameter (LD) of
right and left carotid arteries were calculated according to a method
well used and standardized in our laboratory in obese subjects as
previously reported.32
Statistical Analysis
Values are expressed as the mean  SD. Differences in measure-
ments between the 2 obese groups were analyzed by unpaired t test
after unequal variances analysis. Differences in the prevalence of DD
ACE genotype and insulin-resistant obese subjects in both groups were
analyzed by chi-square test. Linear and multiple regression analyses
were used to calculate correlation coefficients between sE-S, BMI,
WHR, BP, and measurements of left ventricular structure and function
and of carotid morphology. P values .05 were considered statistically
significant.
RESULTS
Central obese subjects were subdivided into 2 groups with
normal (80 ng/mL) and higher (80 ng/mL) sE-S values.
The 2 groups were comparable for gender, age, and height
(Table 1). In contrast, BMI (P  .01), WHR (P  .01), IRI
(P  .001), and 2h-IRI (P  .001) levels were significantly
higher in central obese subjects with higher sE-S values(group
B). In addition, the percentage of subjects with insulin resis-
tance (P  .001) and with DD ACE genotype (P  .01) was
significantly higher in group B than in group A (Table 1).
Hemodynamic, Cardiac, and Carotid Measurements
Casual and ambulatory mean blood pressure (P  .05), TPR
(P  .05) LVM/h (P  .001), and IMWT of both carotid
arteries (P  .05) were significantly higher, whereas LVEF
(P  .01) were significantly lower in central obese subjects
with higher sE-S values than in subjects with normal sE-S
values (Table 2).
Correlation
In all central obese subjects sE-S values were directly cor-
related with WHR (r 0.59; P .001), LVM/h (r 0.51; P
.001), and 2h-IRI (r 0.55; P .001), and inversely correlated
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with LVEF (r  0.69; P  .001) (Figs 1 and 2). Multiple
regression analysis indicated that sE-S levels were indepen-
dently related to LVM/h and LVEF also when age, BMI, and
24-hour MBP were included in the analysis, but only in sub-
jects with the ACE DD genotype (Table 3).
DISCUSSION
The detection of early alterations in left ventricular structure
and function occurs commonly in central obese subjects, as
reported by us in previous studies.4,7,8,29 The results of present
study indicate that there is a clear association between sE-S,
insulin levels, blood pressure, LVM and function, and carotid
wall thickness in centrally obese subjects. In particular, higher
values of BMI, WHR, 2h-IRI, MBPc, 24-hour MBP, LVM/h,
IMWT of both carotid arteries, and TPR, and lower values of
LVEF, were found in group B (higher sE-S) than in group A
(normal sE-S). Several data demonstrated that endothelium-
bound E-selectin and other adhesion molecules have been
detected more commonly in human atherosclerotic lesions than
in healthy arterial tissue.14,33,34 This fact might be explained by
the inflammatory, immune, and hemostatic actions attributed to
endothelium-bound E-selectin under condition of shear-
stress.9,14 This further supports the idea that atherosclerosis
may, in part, be an inflammatory disease. Experimental data
suggest that knock-out mice deficient in E-selectin, P-selectin,
or intracellular adhesion molecule-1 (ICAM-1) develop fewer
arterial lesions than normal mice.33,34 Although increased cell
surface expression of adhesion molecules is difficult to quantify
in vivo, soluble forms can now been measured in serum.35 In
this context there are limited and contrasting clinical data about
the predictive role of circulating adhesion molecules and also
of sE-S on cardiovascular atherosclerotic disease. In fact, re-
cent results from a methanalysis of Malick et al36 do not
demonstrate a significant role of selectin molecules on cardio-
vascular risk. Indeed, results from Atherosclerosis Risk in
Table 1. Clinical Characteristic, Basal and After Oral Glucose
Tolerance Test Insulin Levels, and Prevalence in ACE Genotypes
Between the Two Groups of Central Obese Subjects
Group A,
E-Selectin
80 ng/mL
Group B,
E-Selectin
80 ng/mL P
No. of cases 42 14
M/F 20/22 6/8
Age (yr) 33  5 35  3 NS
Height (cm) 161  9 164  8 NS
BMI (kg/m2) 34  3 38  5 .01
WHR (%) 0.90  0.07 1  0.05 .01
sE-S (ng/mL) 54  13 99.  15 .001
IRIb (pmol/L) 13  8 22  9 .001
2h-IRI (pmol/L) 600  238 994  367 .001
IR (%) 28 (10/42) 79 (11/14) .001*
DD genotype (%) 36 (15/42) 71 (10/14) .01*
DI genotype (%) 28 (12/42) 22 (3/14) NS
II genotype (%) 36 (15/42) 7 (1/14) .01*
Abbreviations: ACE, angiotensin converting enzyme; M/F, males/
females; BMI, body mass index; WHR, waist-hip ratio; sE-S, soluble
E-selectin; IRIb, basal insulin; 2h-IRI, 2-hour insulin after oral glucose
tolerance test; IR, insulin-resistance; NS, not significant.
*Chi-square test.
Table 2. Hemodynamic, Cardiac, and Carotid Measurements in the
Two Groups of Central Obese Subjects
Group A,
E-Selectin
80 ng/mL
Group B,
E-Selectin
80 ng/mL P
No. of cases 42 14
MBPc (mm Hg) 90  8 98  7 .05
MBP/24 h (mm Hg) 90  7 97  6 .05
HR (b/m2) 76  10 75  8 NS
TPR (dynes s  cm5) 1,870  470 2,190  570 .05
LVEF (%) 61  2 56  3 .01
LVM/h (g/m) 87  15 105  15 .001
IMWT/sn (mm) 0.60  0.16 0.69  0.2 .05
IMWT/dx (mm) 0.64  0.12 0.73  0.2 .05
LD dx (mm) 6.2  0.8 6.3  0.9 NS
LD sn (mm) 6.2  0.7 6.4  0.6 NS
Abbreviations: MBPc, casual mean blood pressure; MBP/24 h, 24-
hour MBP; HR, heart rate; TPR, total peripheral resistance; LVEF, left
ventricular ejection fraction; LVM/h, left ventricular mass/height;
IMWT, intima-media wall thickness of left (sn) and right (dx) carotid;
LD, lumen diameter.
Fig 1. Relationship between sE-S levels, 2 hours after oral glucose
tolerance test insulin levels (IRI-2h), and WHR in all subjects studied.
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Communities Study (ARIC)16 indicate a strong association
between concentration of soluble adhesion molecules and cor-
onary heart disease. In particular, the risk of coronary heart
disease is 5 times greater in subjects with raised values of
soluble ICAM-1, and 2 times greater in those with raised sE-S.
More recently, Blankenberg et al15 have reported that levels
of soluble vascular cell adhesion molecule-1 (VCAM-1),
ICAM-1, and E-selectin were significantly related to future
death from cardiovascular causes in patients with documented
coronary artery disease. These authors suggested that measure-
ments of soluble adhesion molecules might provide a better
diagnostic tools for new therapeutic strategies.
In our opinion, these contrasting data might be attributable to
the different design and goal of the studies. To the best our
knowledge, the present study is the first to consider the asso-
ciation between central obesity, E-selectin, ACE genotype, and
early carotid and left ventricular abnormalities.
This might represent an interesting issue, since several com-
mon human vascular diseases are in part a consequence of the
same responses of the endothelium to stress. The prolonged or
exaggerated endothelial activation leads to dysfunction that is
an early, often preclinical component of vascular disease.10
Since we wanted to focus on patients with central obesity by
evaluation of the role of body fat distribution and other cardio-
vascular risk factors, we selected a population of subjects aged
less than 40 years and without major cardiovascular risk factors
to avoid inclusion of subjects with detectable vascular damage.
Our results that higher BMI and WHR values may be de-
tectable in the group with higher sE-S are in agreement with
recent data indicating that obesity per se promotes early endo-
thelial activation and that weight loss counteracts such endo-
thelial activation.17 In addition, it has to be emphasized that
even if the differences in BMI and WHR values between the 2
groups were small, they have a relevant not only statistical but
also biological significance. This is in agreement with our
previous4,5,7,8,25 and with recent epidemiological results,37 in-
dicating that also small changes in BMI and WHR values may
assume an important prognostic significance related to cardio-
vascular risk stratification. In particular, these data support the
existence of a continous gradient of cardiovascular risk with
increasing BMI and WHR values in obese subjects.This finding
might be explained by the known relationship between insulin
resistance and central obesity.4 In fact, the prevalence of sub-
jects with insulin resistance was higher in the group with higher
sE-S and with higher BMI and WHR values than in the group
with lower sE-S. Moreover, the recognition of an higher prev-
alence of subjects with insulin resistance and DD genotype
might also explain the higher values of TPR, MBPc, and
24-hour MBP in central obese subjects with higher levels of
sE-S. The concomitant relationship between sE-S, BMI, WHR,
and blood pressure indicates a strong association between en-
dothelial dysfunction, degree of obesity, central fat distribution,
and risk of hypertension.
The abnormalities observed in carotid morphology and in
LVM and function in young central obese subjects with higher
values of sE-S suggest that these subjects may be characterized
by early manifestations of cardiac dysfunction and carotid
Fig 2. Relationship between sE-S levels, LVEF, andLVM/h in all
subjects studied.
Table 3. Correlation Coefficient in Multiple Regression Analysis: Data From Patients With DD Genotype
Partial Correlation Coefficient
Multiple Correlation
CoefficientLVM/h LVEF Age BMI MBP/24h
E-selectin (ng/mL) 0.602* 0.710* 0.122 0.210 0.221 0.589*
NOTE. Explanatory variables were left ventricular mass/height (LVM/h), left ventricular ejection fraction (LVEF), age, body mass index (BMI) and
24-hour mean blood pressure (MBP/24h). The first value for partial coefficient, for example, is the correlation coefficient between E-selectin and
LVM/h after adjustement for age, BMI, and MBP/24h.
*P  .05.
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atherosclerosis. In fact, it is known that increased LVM and
carotid IMWT are independent predictors both of cardiac and
cerebrovascular events.37-39 The reasons of this association are
still unknown but insulin resistance and deletion in ACE gene
polymorphism might explain it. Accordingly, in our study
population the higher prevalence of subjects with insulin resis-
tance and DD genotype was associated with higher sE-S levels.
In addition, 2h-IRI correlated directly with sE-S, indicating that
insulin resistance might assume a relevant role in the develop-
ment of endothelial dysfunction in central obese subjects. This
finding is in agreement with recent data of Steinberg et al40
indicating that obesity, rather than hyperglycemia, has a more
potent detrimental effect on endothelium-dependent vasodila-
tion. It has been related to a defect in the physiological action
of insulin to enhance endothelium-dependent NO synthesis
release.
Therefore, to ascribe a defect in endothelial function to
obesity/insulin resistance, it is important to rule out other causal
associated factors. Accordingly, in this study we excluded
central obese subjects with diabetes, hypercholesterolemia, and
hypertension. The mechanism by which insulin influences en-
dothelial function is not completely known but it might change
endothelium-dependent vasodilation-vasoconstriction bal-
ance.41 On the other hand, the strong association between the D
allele and higher sE-S extends previous data indicating an
impaired endothelium-dependent vasodilation in healthy young
subjects with the DD genotype.22 Unfortunately, the current
study was not designed to explain the mechanism responsible
of the association between D allele and endothelial dysfunction.
This finding may be interesting and it might suggest that
genetic factors contribute to characterize cardiovascular risk
profile of central obese subjects. Nevertheless, the sample
of subjects with II and DI genotype was small to permit a
strong conclusion; the importance of this association in the
evaluation of cardiac damage in central obese subjects was
supported by multiple regression analysis indicating that sE-S
remains independently related to LVM/h and LVEF only in
subjects with the DD genotype. On the contrary, our data seem
to exclude that circulating E-selectin levels and D allele are
both unrelated expressions of endothelial injury in this popu-
lation.
In conclusion, our data contribute to stress the role of sE-S in
central obesity. Accordingly, central obese subjects with higher
levels of sE-S and homozygous for the D allele of ACE may be
characterized by a higher susceptibility to cardiovascular dis-
ease or events in the future. The interest of these endothelial
and genetic markers will be strictly dependent on the possibility
of a better diagnostic and prognostic stratification. For these
reasons, additional prospective data are needed to confirm this
assumption, but a prolonged clinical and laboratory follow-up
study may be recommended in this particular subset of central
obese subjects.
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